PBIM (135) № 2 2022
Subject of the article
PREDMENSTRUAL SYNDROME AND WOMAN'S QUALITY OF LIFE. EFFICIENCY OF HERBAL DRUGS (144-148)
Authors
Khudoyberdieva Gulruh Sobirovna, Boltayev Anvar Ismatovich, Musurmonov Aminjon Melikulovich, Mamataliev Abdumalik Rasulovich
Institution
Samarkand State Medical University, Republic of Uzbekistan, Samarkand
Abstract
The premenstrual syndrome (PMS) is a pathological symptom that significantly reduces the quality of a woman’s life. The etiology and pathogenesis to date have not been sufficiently studied, but the diagnosis, treatment and prevention that are to be complied with have been identified. The treatment of the PMS should be differentiated, taking into account the overall and the reproductive health of the woman, the concomitant diseases, the degree of severity of ICP, the portability of therapy, etc.
Key words
Premenstrual syndrome, quality of life, Vitex Agnus-castus, Mastodynon, Cyclodinon.
Literature
1. Prilepskaya VN, Ledina AV, Tagiyeva AV, Revazova FSVitex agnus castus: Successful treatment of moderate tosevere premenstrual syndrome Maturitas, 2006, 55(Supplement 1): 55-63 2. Aganezova N.V. Premenstrual syndrome: biological and psychosocial predictors of pathogenesis,clinical picture, rationale for complex therapy Doctoral dissertation, 2011, 372 Ledina AV 3. Premenstrual syndrome: epidemiology, clinic, diagnosis and treatment Abstract of doctoral dissertation, 2014 Management of premenstrual syndrome 4. Green-top Guideline No 48, BJOG, 2016 DOI: 10 1111 / 1471- 0528 14260 November 2016, Royal College of Obstetricians and Gynaecologists NICE 5. Zamani M, Neghab N, Torabian S Therapeuticeffect of Vitex agnus castus in patients with premenstrual syndrome Acta MedIran, 2012, 50: 101–6 6. Prilepskaya V N, Mezhevitinova E A,Sasunova R A , Ivanova EV , Letunovskaya A B , Nabieva K R Results of clinical use of the drugcontaining drospirenone, in women with severe PMSobstetrics and gynecology, 2012, 2: 81-85 7. Mahmoud Rafieian-Kopaei and Mino MovahediSystematic Review of Premenstrual, Postmenstrualand Infertility Disorders of Vitex Agnus CastusElectronic physician, 2017 January, 9 (Issue 1):3685-3689 8. Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei MOxidative stress and Parkinson's disease: New hopes intreatment with herbal antioxidants Curr Pharm Des,2016, 22 (2): 238–46 9. Miraj S, Rafieian-Kopaei, Kiani S Melissa officinalis L: A Review Study With an Antioxidant Prospective J EvidBased Complementary Altern Med, 2016 10. Baharvand-Ahmadi B, Bahmani M, Tajeddini P,Rafieian-Kopaei M, Naghdi N An ethnobotanicalstudy of medicinal plants administered for thetreatment of hypertension J Renal Inj Prev, 2016, 5(3): 123–8 11. Rouhi-Boroujeni H, Rouhi-Boroujeni H, Gharipour M,Mohammadizadeh F, Ahmadi S, Rafieian-Kopaei MSystematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for internist Acta biomed, 2015, 86 (2): 130–6 12. Khalilzadeh E,Vafaei Saiah G, Hasannejad H,Ghaderi A, Ghaderi S, Hamidian G, et alAntinociceptive effects, acute toxicity and chemicalcomposition of Vitex agnus-castus essential oil. Avicenna J Phytomed, 2015, 5(3): 218–30. 13. He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, et al. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multicenter place bo controlled study in China. Maturitas,2009, 63(1): 99–103. 14. Jang SH, Kim DI, Choi MS. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement AlternMed, 2014, 14: 11. 15. Weisz G, Knaapen L. Diagnosing and treating premenstrual syndrome in five western nations. Soc SciMed, 2009, 68(8): 1498–505. 16. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol,2003, 18(3): 191–5. 17. Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X.Evaluating therapeutic effect in symptoms of moderate- to - severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynaecol, 2010, 50(2): 189–93. 18. Kelderhouse K1, Taylor JS. A review of treatmentand management modalities for premenstrual dysphoricdisorder. Nurs Womens Health, 2013 Aug-Sep,17(4): 294-305. 19. Birgit M. Dietz, Atieh Hajirahimkhan, Tareisha L.Dunlap, and Judy L. Botanicals and Their BioactivePhytochemicals for Women’s Health. Pharmacol Rev,2016 Oct, 68(4): 1026–1073. 20. Rafieian-Kopaei M, Saki K, Bahmani M, GhafourianS, Sadeghifard N, Taherikalani M. ListeriosisPhytotherapy: A Review Study on the Effectivenessof Iranian Medicinal Plants in Treat-ment of Listeriosis. J Evid Based Complementary Altern Med,2015 21. M. Diana van Die, Henry G. Burger, Helena J. Teede, Kerry M. Bone. Vitex agnus-castus Extracts forFemale Reproductive Disorders: A Systematic Review of Clinical Trials. Women’s Health. Planta Med,2013, 79(07): 562-575. 22. Bahmani M, Sarrafchi A, Shirzad H, Rafieian-KopaeiM. Autism: Pathophysiology and Promising HerbalRemedies. Curr Pharm Des, 2016, 22(3): 277–85. 23. Ambrosini A, Di Lorenzo C, Coppola G, Pierelli F. Useof Vitex agnus-castus in migrainous women withpremenstrual syndrome: an open-label clinicalobservation. Acta Neurol Psychiatr Belg, 2013, 113(1):25–9. 24. Webster DE, He Y, Chen SN, Pauli GF, FarnsworthNR, Wang ZJ. Opioidergic mechanisms underlyingthe actions of Vitex agnus-castus L. Biochem pharmacol,2011, 81(1): 170–7. 25. van Die MD, Bone KM, Burger HG, Reece JE, TeedeHJ. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from as ub population analysis. J Altern Complement Med,2009, 15(9): 1045–8. 26. Royal College of Obstetricians and Gynaecologists/NAPS Guidelines on Guidelines on Premenstrual Syndrom. 01/12/2016. 27. Marjoribanks J1, Brown J, O’Brien PM, Wyatt K.Selective serotonin reuptake inhibitors for premenstrualsyndrome. Cochrane Database Syst Rev, 2013Jun 7, 6: CD001396. 28. Upchurch DM, Chyu L, Greendale GA, Utts J, Bair YA,Zhang G, Gold EB. Complementary and alternativemedicine use among American women: findingsfrom The National Health Interview Survey, 2002. JWomenʼs Health (Larchmt), 2007, 16: 102-113. 29. Zamani M, Neghab N, Torabian S. Therapeutic effectof Vitex agnus castus in patients with premenstrualsyndrome. Acta Med Iran, 2012, 50(2): 101–6. 30. Ledina А.V., Prilepskaya V.N., Droopnene-containing contraceptives: preventive and curative aspects of the use. Gynecology, 2015, 17(1): 25-29. 31. Lauritzen C, Reuter HD, Repges R, Bohnert KJ,Schmidt U. Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, doubleblind study versus pyridoxine. Phytomedicine, 1997,4(3): 183–9. 32. Andrade C. Premenstrual dysphoric disor-der:General overview, treatment strategies, and focuson sertraline for symptom-onset dosing. Indian JPsychiatry, 2016 Jul-Sep, 58(3): 329- 331. 33. Ryu A, Kim TH. Premenstrual syndrome: A minireview. Maturitas, 2015 Dec, 82(4): 436-40.